Patent ID: 8491901
Filing Date: 2013-07-23
Classification: A61K,A61P,C07K,G01N

Abstract:
1. A monoclonal anti-human CCL20 antibody or an antigen-binding portion thereof, whose heavy chain complementarity determining region 1 (CDR1), complementarity determining region 2 (CDR2), and complementarity determining region 3 (CDR3) and whose light chain CDR1, CDR2, and CDR3 comprise amino acid sequences selected from the group consisting of: a) the amino acid sequences shown in SEQ ID NOS: 60, 64, 67, 70, 73, and 75, respectively; b) the amino acid sequences shown in SEQ ID NOS: 60, 64, 67, 71, 73, and 75, respectively; c) the amino acid sequences shown in SEQ ID NOS: 77, 79, 67, 70, 73, and 75, respectively; and d) the amino acid sequences shown in SEQ ID NOS: 77, 79, 67, 71, 73, and 75, respectively.